We are live on ! Find out more
1CM

1492 Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 61.9%
This Fund
S&P 500
This Quarter Est. Return
+20.03%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$176M
AUM Growth
+$2.1M
Cap. Flow
-$16.2M
Cap. Flow %
-9.24%
Top 10 Hldgs %
34.9%
Holding
129
New
28
Increased
19
Reduced
42
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Consumer Discretionary 17.54%
3 Healthcare 13.77%
4 Financials 10.59%
5 Industrials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROCHW
126
DELISTED
Roth CH Acquisition I Co. Warrant
ROCHW
-159,604
Closed -$702K
ROCH
127
DELISTED
Roth CH Acquisition I Co. Common Stock
ROCH
-212,825
Closed -$3.43M
BMCH
128
DELISTED
BMC Stock Holdings, Inc
BMCH
-45,877
Closed -$2.46M
BDSI
129
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-790,863
Closed -$3.32M

Similar funds

1492 Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, 1492 Capital Management held 129 positions worth $176M, up 1.2% from $174M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

1492 Capital Management withdrew a net $16.2M in Q1 2021, closing 29 positions and reducing 42 holdings. Its most notable exit was NeoGenomics, an estimated $4.87M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, 1492 Capital Management opened a new position in PureCycle Technologies Inc Warrant worth $2.18M.

  • 1492 Capital Management's largest Q1 2021 buy was PureCycle Technologies Inc Warrant: 156,959 shares worth $2.18M.
  • 1492 Capital Management added most to MaxLinear in Q1 2021, an estimated $2.91M increase.
  • 1492 Capital Management's biggest Q1 2021 reduction was Digital Turbine, cutting an estimated $2.58M.
  • 1492 Capital Management fully exited NeoGenomics in Q1 2021, selling an estimated $4.87M.
  • 1492 Capital Management's ten largest holdings make up 35% of its $176M portfolio in Q1 2021.
  • 1492 Capital Management opened 28 new positions and closed 29 in Q1 2021.
  • 1492 Capital Management's portfolio value rose 1.2% quarter-over-quarter to $176M.

Based on 1492 Capital Management's 13F filing for Q1 2021, filed 12 May 2021.